The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.

MLA

Kaiser, Martin F., et al. “The Proteasome Inhibitor Bortezomib Stimulates Osteoblastic Differentiation of Human Osteoblast Precursors via Upregulation of Vitamin D Receptor Signalling.” European Journal of Haematology, vol. 90, no. 4, Apr. 2013, pp. 263–72. EBSCOhost, https://doi.org/10.1111/ejh.12069.

APA

Kaiser, M. F., Heider, U., Mieth, M., Zang, C., von Metzler, I., & Sezer, O. (2013). The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling. European Journal of Haematology, 90(4), 263–272. https://doi.org/10.1111/ejh.12069

Chicago

Kaiser, Martin F, Ulrike Heider, Maren Mieth, Chuanbing Zang, Ivana von Metzler, and Orhan Sezer. 2013. “The Proteasome Inhibitor Bortezomib Stimulates Osteoblastic Differentiation of Human Osteoblast Precursors via Upregulation of Vitamin D Receptor Signalling.” European Journal of Haematology 90 (4): 263–72. doi:10.1111/ejh.12069.